Rahul Ballal is the founder of Mediar Therapeutics. Mediar Therapeutics has raised $181M in total funding. Latest round: Series A.
Rahul Ballal is a pharmaceutical industry veteran and the chief executive officer of Mediar Therapeutics, a clinical-stage biotechnology company focused on developing first-in-class therapies for fibrosis. He was appointed CEO as the startup advanced its $85 million Series A financing round in March 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library